Abstract
Eosinophilic gastroenteritis is a rare gastrointestinal (GI) disorder of undetermined cause characterized by infiltration of eosinophils in the GI tract. Eosinophils accumulate in tissues and may release highly cytotoxic granular proteins, which cause severe tissue damage characteristic of eosinophilic gastroenteritis. Eotaxin may play a role in the recruitment of eosinophils into tissue in combination with chemoattractants and cytokines, including interleukin 3 and 5 and granulocyte-macrophage colony-stimulating factor. Food allergy, especially in children, can be a triggering factor, and an amino acid-based diet may be helpful. Accumulation of eosinophils in the gut is a common feature in food-induced GI disorders that can be regulated through a complex molecular network involving Th2 cells, various cytokines, and chemokines. Eosinophilic gastroenteritis has a wide spectrum of clinical presentation depending on the site of involvement. It may be confused with irritable bowel syndrome or dyspepsia and, rarely, mimics pancreatitis or appendicitis. Diagnosis is important and is usually made by a pathologist. Eosinophilic gastroenteritis is a treatable disease; patients generally respond to steroid therapy, although relapse is common. Non-enteric-coated budesonide, a locally acting corticosteroid with little risk of adrenal suppression, may be substituted, although more experience is needed. Promising new drugs for eosinophilic gastroenteritis include montelukast, a selective leukotriene receptor antagonist, and suplaplast tosilate, a selective Th2 cytokine inhibitor with inhibitory effects on allergy-induced eosinophilic infiltration and IgE production. Although it is likely a separate disease, more experience has accumulated, and an elimination or specific amino acid-based diet appears to be helpful in treatment.
Similar content being viewed by others
References and Recommended Reading
Ureles AL, Alschibaja T, Lodico D, et al.: Idiopathic eosinophilic infiltration of the gastrointestinal tract, diffuse and circumscribed: a proposed classification and review of the literature, with two additional cases. Am J Med 1961, 30:899–909.
Klein NC, Hargrove R, Sleisenger MH, et al.: Eosinophilic gastroenteritis. Medicine 1970, 49:299–319.
Cello JP: Eosinophilic gastroenteritis: a complex disease entity. Am J Med 1979, 67:1097–1104.
Talley NJ, Shorter RG, Phillips SF, et al.: Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosae, muscle layer, and subserosal tissues. Gut 1990, 31:54–58.
Kaijser R: Zur Kenntnis der allergischen Affektionen des Verdauungskanals vom Standpunkt des Chirurgen aus. Arch Klin Chir 1937, 188:36–64.
Naylor AR: Eosinophilic gastroenteritis. Scot Med 1990, 35:163–165.
Lee C-M, Changshien CS, Chen P-C, et al.: Eosinophilic gastroenteritis: 10 years experience. Am J Gastroenterol 1993, 88:70–74.
KellyKJ, Eosinophilic gastroenteritis. J Pediatr Gastroenterol Nutr 2000, 30(suppl):S28-S35. Excellent review of current immunologic and clinical concepts in pediatric eosinophilic gastroenteritis.
Kay MH, Wyllie R, Steffen RM: The endoscopic appearance of eosinophilic gastroenteritis in infancy. Am J Gastroentrol 1995, 90:1361–1362.
Whitington PF, Whitington GL: Eosinophilic gastropathy in childhood. J Pediatr Gastroenterol Nutr 1988, 7:379–385.
Moore D, Lichtman S, Lentz J, et al.: Eosinophilic gastroenteritis presenting in an adolescent with isolated colonic involvement. Gut 1986, 27:1219–1222.
Redondo-Cerezo E, Cabello Y, Gonzalez M, et al.: Eosinophilic gastroenteritis: our recent experience: one year experience of atypical onset of an uncommon disease. Scand J Gastroenterol 2001, 36:1358–1360.
Robert F, Omura E, Durant JR: Mucosal eosinophilic gastroenteritis with systemic involvement. Am J Med 1977, 62:39–43.
Gregg JA, Utz DC: Eosinophilic cystitis associated with eosinophilic gastroenteritis. Mayo Clin Proc 1974, 49:185–187.
Van den Ouden D: Diagnosis and management of eosinophilic cystitis: a pooled analysis of 135 cases. Eur Urol 2000, 37:386–394.
Weller PF: The immunobiology of eosinophils. N Engl J Med 1991, 324:110–118.
Gleich GJ, Adolphson CR: The eosinophilic leukocyte: structure and function. Adv Immunol 1986, 39:177–253.
Giembycz MA, Lindsay MA: Pharmacology of eosinophil. Pharmacol Rev 1999, 51:213–340.
Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76:301–314.
Rankin SM, Conroy DM, Williams TJ: Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today 2000, 6:20–27. Fascinating review of eotaxin, an eosinophil-specific chemoattractant that may control recruitment of eosinophils to the gut.
Shaw RJ, Walsh GM, Cromwell O, et al.: Activated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulation. Nature 1985, 316:150–152.
Talley NJ, Kephart GM, McGovern TW, et al.: Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. Gastroenterology 1992, 103:137–145.
Bischoff SC, Mayer J, Nguyen QT, et al.: Immunohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease. Am J Gastroenterol 1999, 94:3521–3529.
Kato M, Kephart GM, Talley NJ, et al.: Eosinophil infiltration and degranulation in normal human tissue. Anat Rec 1998, 252:418–425.
Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, et al.: Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996, 2:449–456.
Elsner J,Hochstetter R,Kimmig D,Kapp A: Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur J Immunol 1996, 26:1919–1925.
Tenscher K, Metzner B, Schopf E, et al.: Recombinant human eotaxin induces oxygen radical production, Ca (2+)mobilization, action reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. Blood 1996, 88:3195–3199.
Burke-Gaffiney A, Hellewell PG: Eotaxin stimulates eosinophil adhesion to human lung microvascular endothelial cells. Biochem Biophys Res Commun 1996, 227:35–40.
Collins PD, Marleau S, Griffiths-Johnson DA, et al.: Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995, 182:1169–1174.
Jose PJ, Griffiths-Johnson DA, Collins PD, et al.: Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea-pig model of allergic airways inflammation. J Exp Med 1994, 179:881–887.
Teixeira MM, Wells TN, Lukacs NW, et al.: Chemokine-induced eosinophil recruitment: evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J Clin Invest 1997, 100:1657–1666.
Sanz M-J, Ponath PD, Mackay CR, et al.: Human eotaxin induces G4 and B2 integrin-dependent eosinophil accumulation in rat skin in vivo: delayed generation of eotaxin in response to IL-4. J Immunol 1998, 160:3569–3576.
Ponath PD, Qin S, Ringler DJ, et al.: Cloning of the human eosinophil chemoattractant, eotaxin: expression, receptor binding and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Immunol 1996, 97:604–612.
Forssmann U, Ugucchioni M, Loetscher P, et al.: Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts likes eotaxin on human eosinophil and basophil leukocytes. J Exp Med 1997, 185:2171–2176.
Kitaura M, Nakajima T, Imai T, et al.: Molecular cloning of human eotaxin, an eosinophil-selective CC Chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem 1996, 271:7725–7730.
White JR, Imburgia C, Dul E, et al.: Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophil. J Leukoc Biol 1997, 62:667–675.
Shinkai A, Yoshisue H, Koike M, et al.: A novel human CC chemokine, eotaxin-3, which is expressed in IL-4, stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J Immunol 1999, 163:1602–1610.
Beil WJ, Weller PF, Tzizik DM, et al.: Ultrastructural immunogold localization of tumour necrosis factor-alpha to the matrix compartment of eosinophil secondary granules in patients with idiopathic hypereosinophilic syndrome. J Histochem Cytochem 1993, 41:1611–1615.
Hamelmann E, Gelfand EW: Role of interleukin-5 in the development of allergen-induced airway hyperresponsiveness. Int Arch Allergy Immunol 1999, 120:8–16.
Wardlaw AJ: Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J Allergy Clin Immunol 1999, 104:917–926.
Beyer K, Castro R, Birnbaum A, et al.: Human milk-specific mucosal lymphocytes of the gastrointestinal tract display a TH2 cytokine profile. J Allergy Clin Immunol 2002, 109:707–713. In this study, the cytokine profiles of milk-specific lymphocytes from duodenal mucosal biopsies of children with milk-induced GI disorders, and the pathogenic role of Th2 cytokines in the inflammatory changes of milk-induced allergy, are described.
Deveries E: The role of interleukin-13 and its receptor in allergy and inflammatory response. J Allergy Immunol 1998, 102:165–169.
Romagnani S: The role of lymphocytes in allergic disease. J Allergy Clin immunol 2000, 105:399–408.
Hamid QA, Minshall EM: Molecular pathology of allergic disease 1. Lower airway disease. J Allergy Clin Immunol 2000, 105:20–36.
Bischoff SC, Mayer JH, Manns MP: Allergy and the gut. Int Arch Allergy Immunol 2000, 121:270–283.
Crowe SE: Gastrointestinal food allergies: do they exist? Curr Gastroentrol Rep 2001, 3:351–357.
Leinbach GE, Rubin CE: Eosinophilic gastroenteritis: a simple reaction to food allergens? Gastroenterology 1970, 59:874–889.
Talley NJ: Eosinophilic gastroenteritis. In Sleisenger and Fordtran’s Gastrointestinal Disease: Pathophysiology, Diagnosis and Management, edn 7. Edited by Feldman M, Scharschmidt BF, Sleisenger MH. Philadelphia: WB Saunders; 2001.
Croese J, Loukas A, Opdebeeck J, et al.: Occult enteric infection by Ancylostoma caninum: a previously unrecognized zoonosis. Gastroenterology 1994, 106:3–12.
Croese J, Loukas A, Opdebeeck J, et al.: Human enteric infection with canine hookworms. Ann Intern Med 1994, 120:369–374.
Prociv P, Croese J: Human eosinophilic enteritis caused by dog hookworm Ancylostoma caninum. Lancet 1990, 335:1299–1302.
Khoshoo V, Schantz P, Craver R, et al.: Dog hookworm: a cause of eosinophilic enterocolitis in humans. J Pediatr Gastroenterol 1994, 19:448–452.
Michet CJ Jr, Rakela J, Luthra HS: Auranofin associated with colitis and eosinophilia. Mayo Clin Proc 1987, 62:142–144.
Wienand B, Sanner B, Liersch M: Eosinophilic gastroenteritis as an allergic reaction to trimethoprim-sulfonamide preparation. Dtsch Med Wochenschr 1991, 116:371–374.
Anttila VJ, Valtonen M: Carbamazepine-induced eosinophilic colitis. Epilepsia 1992, 33:119–121.
Ravi S, Holubka J, Veneri R, et al.: Clofazimine-induced eosinophilic gastroenteritis in AIDS [letter]. Am J Gastroenterol 1993, 88:612–613.
Barak N, Hart J, Sitrin MD: Enalapril induced eosinophilic gastroenteritis. J Clin Gastroenterol 2001, 33:157–158.
Lee JY, Medellin MV, Tumpkin C: Allergic reaction to Gemfibrozil manifesting as eosinophilic gastroenteritis. South Med J 2000, 93:807–808.
Dhawan A, Seemayer TA, Pinsinski C, et al.: Post transplant eosinophilic gastroenteritis in children. Liver Transplant Surg 1997, 3:591–593.
Katz AJ, Goldman H, Grand RJ: Gastric mucosal biopsy in eosinophilic (allergic) gastroenteritis. Gastroenterology 1977, 73:705–709.
Liacouras CA, Markowitz JE: Eosinophilic esophagitis: a subset of eosinophilic gastroenteritis. Curr Gastroentrol Rep 1999, 1:253–258.
Orenstein SR, Shalaby TM, Lorenzo CD, et al.: The spectrum of pediatric eosinophilic oesophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol 2000, 95:1422–1430. This report represents the largest series of pediatric eosinophilic esophagitis collected and illustrates the spectrum of disease and its treatment, as well as associations with other conditions.
Walsh SV, Antonioli DA, Goldman H, et al.: Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol 1999, 23:390–396.
Naylor AR, Pollet JE: Eosinophilic colitis. Dis Colon Rectum 1985, 28:615–618.
Schoonbroodt D, Horsmans Y, Laka A, et al.: Eosinophilic gastroenteritis presenting with colitis and cholangitis. Dig Dis Sci 1995, 402:308–314.
Matsushita M, Hajiro K, Morita Y, et al.: Eosinophilic gastroenteritis involving the entire digestive tract. Am J Gastroenterol 1995, 90:1868–1870.
Weisberg SC and Crosson JT: Eosinophilic gastroenteritis: report of case of 32 years’ duration. Am J Dig Dis 1973, 18(11):1005–1014.
Everett GD, Mitros FA: Eosinophilic gastroenteritis with hepatic eosinophilic granulomas: report of a case with 30-year follow-up. Am J Gastroenterol 1980, 74:519–521.
Kalantar SJ, Marks R, Lambert JR, et al.: Dyspepsia due to eosinophilic gastroenteritis. Dig Dis Sci 1997, 42:2327–2332.
Maeshima A, Murakami H, Sadakata H, et al.: Eosinophilic gastroenteritis presenting with acute pancreatitis. J Med 1997, 28:265–272.
Euscher E, Vaswani K, Frankel W: Eosinophilic pancreatitis: a rare entity that can mimic a pancreatic neoplasm. Ann Diagn Pathol 2000, 4:379–385.
Madhotra R, Eloubeidi MA, Cunningham JT, et al.: Eosinophilic gastroenteritis: masquerading as ampullary adenoma. J Clin Gastroenterol 2002, 34:240–242.
Butterfield JH, Murray JA: Eosinophilic gastroenteritis and gluten-sensitive enteropathy in the same patient. J Clin Gastroentrol 2002, 34:552–523.
Thomas DW, Talley NJ, Mahnovski V, et al.: Rectal mucosal major basic protein in infants with dietary protein-induced colitis. Ann Allergy 1993, 71:66–69.
Goldman H, Proujansky R: Allergic proctitis and gastroenteritis in children: clinical and mucosal biopsy features in 53 cases. Am J Surg Pathol 1986, 10:75–86.
Moon A, Kleinman RE: Allergic gastroenteropathy in children. Ann Allergy 1995, 74:5–12.
Goldstein NA, Putnam PE, Dohar JE: Laryngeal cleft and eosinophilic gastroenteritis: report of 2 cases. Arch Otolaryngol Head Neck Surg 2000, 126:227–230.
Shweiki E, West JC, Klena JW, et al.: Eosinophilic gastroenteritis presenting as an obstructing caecal mass: a case report and review of the literature. Am J Gastroenterol 1999, 94:3644–3645.
Redondo-Cerezo E, Moreno Platero JJ, Garcia Dominguez E, et al.: Comments to a report: eosinophilic gastroenteritis presenting as an obstructing caecal mass: review literature and our own experience. Am J Gastroentrol 2000, 95:3655–3657.
Tran D, Salloum L, Tshibaka et al.: Eosinophilic gastroenteritis mimicking acute appendicitis. Am Surg 2000, 66:990–992.
Kelly K, Lazenby A, Rowe P, et al.: Eosinophilic oesophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995, 109:1503–1512.
Sicherer SH, Noone SA, Koerner CB, et al.: Hypoallergenicity and efficacy of an amino acid-based formula in children with cow’s milk and multiple food hypersensitivities. J Pediatr 2001, 138:688–693.
McNabb PC, Fleming CR, Higgins JA, et al.: Transmural eosinophilic gastroenteritis with ascites. Mayo Clin Proc 1979, 54:119–122.
Carpenter HA, Talley NJ: The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications. Am J Gastroenterol 2000, 95:878–896.
Lee M, Hodges WG, Huggins TL, et al.: Eosinophilic gastroenteritis. South Med J 1996, 89:189–194.
Solis-Herruzo J, de Cuenca B, Munoz-Yagüe MT: Laparoscopic findings in serosal eosinophilic gastroenteritis: report of two cases. Endoscopy 1988, 20:152–153.
Fortman LM, Johanson JF, Baskin WN, et al.: Eosinophilic ascites without eosinophilia: a unique presentation of serosal eosinophilic gastroenteritis. Am J Gastroenterol 1993, 88:1280–1281.
Bischoff SC, Mayer J, Wedemeyer J, et al.: colonoscopic allergen provocation (COLAP) a new diagnostic approach for gastrointestinal food allergy. Gut 1997, 40:745–753.
Justinich C, Katz A, Gurbindo C, et al.: Elemental diet improves steroid-dependent eosinophilic gastroenteritis and reverses growth failure. J Pediatr Gastroenterol Nutr 1996, 23:81–85.
Pfaffenbach G, Adamek RJ, Bethke B, et al.: Eosinophilic gastroenteritis in food allergy. Z Gastroenterol 1996, 34:490–493.
Tan AC, Kruimel JW, Naber TH: Eosinophilic gastroenteritis treated with non-enteric coated budesonide tablets. Eur J Gastroenterol Hepatol 2001, 13:425–427.
Van Dellen RG, Lewis JC: Oral administration of cromolyn in a patient with protein-losing enteropathy, food allergy, and eosinophilic gastroenteritis. Mayo Clin Proc 1994, 69:441–444.
Perez-Millan A, Martin-Lorente JL, Lopez-Morante A, et al.: Subserosal eosinophilic gastroenteritis treated efficaciously with sodium cromglycate. Dig Dis Sci 1997, 42:342–344.
Keshavarizian A, Saverymuttu SH, Tai P-C, et al.: Activated eosinophils in familial eosinophilic gastroenteritis. Gastroenterology 1985, 88:1041–1049.
Paganelli R, Levinsky RJ, Brostoff J, et al.: Immune complexes containing food proteins in normal and atopic subjects after oral challenge and effect of sodium cromoglycate on antigen absorption. Lancet 1979, 1:1270–1272.
Neustrom MR, Friesen C: Treatment of eosinophilic gastroenteritis with montelukast. J Allergy Clin Immunol 1999, 104:506.
Schwartz DA, Pardi DS, Murray JA: Use of montelukast as steroid sparing agent for recurrent eosinophilic gastroenteritis. Dig Dis Sci 2001, 46:1787–1790.
Yamaya H, Basaki M, Tokawa M, et al.: Down regulating of TH2 cell mediated marine peritoneal eosinophilia by antiallergic agents. Life Sci 1995, 56:1647–1654.
Zhao GD, Yokoyama A, Kohno N, et al.: Effect of Suplatast tosilate (IPD-1151 T) on a mouse model of asthma inhibition of eosinophilic inflammation and bronchial hyperresponsiveness. Int Arch Allergy Immunol 2000, 121:116–122.
Shim JJ, Dabbagh K, Takeyama K, et al.: Suplatast tosilate inhibits goblet-cell metaplasia of airway epithelium in sensitized mice. J Allergy Clin Immunol 2000, 105:739–745.
Tamaoki J, Kondo M, Sakaj N, et al.: Effect of Suplatast tosilate TH2 cytokine inhibitor on steroid dependent asthma: a double blind randomised study. Lancet, 2000, 365:273–278.
Shirai T, Hashimoto D, Suzuki K, et al.: Successful treatment of eosinophilic gastroenteritis with Suplatast tosilate. J Allergy Clin Immunol 2001, 107:924–925. Report of successful treatment with a selective Th2 cytokine inhibitor.
Melamed I, Feanny SF, Sherman PM, et al.: Benefit of ketotifen in patients with eosinophilic gastroenteritis. Am J Med 1991, 90:310–314.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Daneshjoo, R., Talley, N.J. Eosinophilic gastroenteritis. Curr Gastroenterol Rep 4, 366–372 (2002). https://doi.org/10.1007/s11894-002-0006-2
Issue Date:
DOI: https://doi.org/10.1007/s11894-002-0006-2